CHEST 2020: Questions Remain Around Link Between Vitamin D and ICU Outcomes
With low levels of vitamin D in critically ill patients with COVID-19 reported in numerous recent...
Read More
Meeting Coverage
Phase III ADAURA Trial: CNS Recurrences slashed for NSCLC
Physician’s Weekly interviews principle investigator, Roy S. Herbst, MD, PhD, Ensign...
Read More
FMX 2020: Pediatric Supracondylar Fractures of the Humerus & Playground Equipment Safety
New research was presented at FMX 2020, the 2020 American Academy of Family Physicians virtual...
Read More
FMX 2020: Are Marijuana & Obesity Linked?
New research was presented at FMX 2020, the 2020 American Academy of Family Physicians virtual...
Read More
FMX 2020: Structured Yoga Program Decreases Dysmenorrhea-Associated Pain
New research was presented at FMX 2020, the 2020 American Academy of Family Physicians virtual...
Read More
FMX 2020: Involving Adolescents in Medical Decision Making
New research was presented at FMX 2020, the 2020 American Academy of Family Physicians virtual...
Read More
FMX 2020: Project Improves Parent-School-Provider Communication
New research was presented at FMX 2020, the 2020 American Academy of Family Physicians virtual...
Read More
ACTRIMS-ECTRIMS: Ofatumumab Shows Efficacy in New MS Patients
Once-monthly injections allows patients to control their treatment schedule In a group of...
Read More
AAP: Racial Disparity Observed in Child Abuse Reporting
New research was presented at AAP 2020, the 2020 American Academy of Pediatrics Virtual National...
Read More
AAP: Widespread Pre-Sports ECG Screening Is Feasible
New research was presented at AAP 2020, the 2020 American Academy of Pediatrics Virtual National...
Read More
AAP: Firearm Deaths Most Common in Poorest Counties
New research was presented at AAP 2020, the 2020 American Academy of Pediatrics Virtual National...
Read More
AAP: Protocol Reduces Flu Vaccine Hesitancy
New research was presented at AAP 2020, the 2020 American Academy of Pediatrics Virtual National...
Read More
AAP: Risk Behaviors Relatively Common in Gender Diverse Youth
New research was presented at AAP 2020, the 2020 American Academy of Pediatrics Virtual National...
Read MoreECTRIMS 2020 Encore Event: NG-Specific Biomarkers Can Quickly Differentiate NMOSD from MS
Neutrophil granulocyte (NG)-specific biomarkers have high sensitivity and specificity for rapid differentiation between acute neuromyelitis optica spectrum disorders (NMOSD), anti-MOG-antibody associated disease (MOGAD), and...
Read MoreECTRIMS 2020 Encore Event: Interrupting DMT Due to Pregnancy Increases NfL Levels in MS
During pregnancy and the disease-modifying treatment (DMT)-free postpartum period, serum neurofilament-light (sNfL) levels were augmented [1]. This increase was independent of relapses, suggesting increased subclinical disease...
Read MoreECTRIMS 2020 Encore Event: Brain Alterations at Onset of First Demyelinating Event
Neurite orientation dispersion and density imaging (NODDI) can detect brain microstructural and metabolic alterations after the first demyelinating event in MS [1]. There was increased axonal dispersion in normal-appearing white...
Read MoreECTRIMS 2020 Encore Event: MS Patients Have No Increased Risk of Contracting COVID-19
People with MS are not more susceptible to COVID-19 infection than the UK general population, suggest results of the largest community-based study of COVID-19 in people with MS worldwide [1]. During lockdown, with strict...
Read MoreFunctional Potential of Gut Microbiome in Pediatric MS
No overall differences in the functional diversity of the gut microbiome were found in patients with pediatric-onset MS in a study using metagenomic sequencing. However, there were differences in the functional potential...
Read MoreGold Nanocrystals May Improve Brain Metabolic Profile
Interim results from two phase 2 studies provide evidence that orally delivered CNM-Au8 (gold nanocrystals) have catalytic effects on key bioenergetic metabolites in the brain of patients with MS and Parkinson’s disease...
Read MoreEculizumab Reduces Long-Term Relapse Risk in AQP4+ NMOSD
Long-term efficacy and safety results of eculizumab monotherapy in patients with aquaporin-4 IgG-positive (AQP4+) neuromyelitis optica spectrum disorder (NMOSD) during the PREVENT trial and/or its ongoing open-label extension...
Read More